Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol

Antonio Molino, Giovanna Calabrese, Mauro Maniscalco
  • Patient Preference and Adherence, June 2018, Dove Medical Press
  • DOI: 10.2147/ppa.s152179

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

The following have contributed to this page: Dr Mauro Maniscalco